Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

KNSAKNSA

Showing 0 of 22 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in KINIKSA PHARMACEUTICALS-A

As of its Q1 2024 13F, Baker Bros. Advisors held 2,809,577 shares of KNSA (Kiniksa Pharmaceuticals), worth $55.4M. Baker Bros. Advisors' 13F filings listed KNSA from Q1 2019 to Q1 2024, 21 quarterly filings. KNSA was 0.7% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used